Ontology highlight
ABSTRACT: Objectives
To assess the efficacy and safety of omalizumab for chronic rhinosinusitis with nasal polyps (CRSwNP) and to identify evidence gaps that will guide future research on omalizumab for CRSwNP.Design
Systematic review and meta-analysis.Data sources
A comprehensive search was performed in PubMed, Embase, Web of Science and the Cochrane Library on 13 October 2020.Eligibility criteria
Randomised controlled trials (RCTs) comparing omalizumab with placebo, given for at least 16 weeks in adult patients with CRSwNP.Data extraction and synthesis
Two independent authors screened search results, extracted data and assessed studies using the Cochrane risk of bias tool. Data were pooled using the inverse-variance method and expressed as mean differences (
SUBMITTER: Wu Q
PROVIDER: S-EPMC8420736 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature